Ad Code: Rinvoq - Display Banners Peer to Peer - August - 99709

Proactive pain management in patients with IBD, using a bundle with acetaminophen, gabapentin, and NSAIDs, reduces opioid use and maintains effective pain control.

Gastroenterologists can play a key role in managing substance misuse in Crohn’s disease, both in the exam room and through referral to mental health clinicians.

Charles Berstein, MD, discusses the challenges linked to managing substance abuse among patients with Crohn’s Disease.

Gastroenterologists can use single-item tools like the National Institute on Drug Abuse Quick Screen to assess substance use in patients with Crohn’s disease.

The limited data available shows that patients with Crohn’s disease may be more likely to misuse substances than the general population.

Patients who develop CDP after IPAA often face significantly lower QOL with a higher risk of septic complications and pouch failure.

A study examining 20 years of data shows that race, ethnicity, and geography impact disease severity in patients with IBD.